Roberta Tesch

659 total citations
20 papers, 520 citations indexed

About

Roberta Tesch is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Roberta Tesch has authored 20 papers receiving a total of 520 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in Roberta Tesch's work include Synthesis and biological activity (3 papers), Synthesis of Tetrazole Derivatives (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Roberta Tesch is often cited by papers focused on Synthesis and biological activity (3 papers), Synthesis of Tetrazole Derivatives (3 papers) and Cancer, Hypoxia, and Metabolism (2 papers). Roberta Tesch collaborates with scholars based in Germany, Brazil and Finland. Roberta Tesch's co-authors include Carlos Alberto Manssour Fraga, Eliezer J. Barreiro, Stefan Laufer, Carlos Maurício R. Sant’Anna, Lı́dia Moreira Lima, Michael H.G. Kubbutat, Christoph Schächtele, Frank Totzke, Maria Letícia de Castro Barbosa and Stefan Knapp and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Journal of Medicinal Chemistry.

In The Last Decade

Roberta Tesch

19 papers receiving 501 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Roberta Tesch Germany 14 263 217 78 76 63 20 520
Clive McCarthy United Kingdom 16 255 1.0× 271 1.2× 99 1.3× 68 0.9× 64 1.0× 29 673
Ingo V. Hartung Germany 14 315 1.2× 477 2.2× 39 0.5× 70 0.9× 56 0.9× 36 906
Robert T. Lum United States 16 332 1.3× 329 1.5× 29 0.4× 135 1.8× 30 0.5× 19 759
Friederike Stoll Germany 9 274 1.0× 66 0.3× 39 0.5× 39 0.5× 130 2.1× 20 531
Paolo Di Fruscia United Kingdom 10 332 1.3× 352 1.6× 48 0.6× 115 1.5× 33 0.5× 15 980
Michael Härter Germany 10 176 0.7× 314 1.4× 20 0.3× 42 0.6× 27 0.4× 13 595
Ian L. Dale United Kingdom 16 455 1.7× 67 0.3× 28 0.4× 98 1.3× 60 1.0× 25 672
Robert H. Bradbury United Kingdom 15 279 1.1× 343 1.6× 47 0.6× 153 2.0× 69 1.1× 34 623
Esther Marco Spain 15 342 1.3× 225 1.0× 80 1.0× 117 1.5× 24 0.4× 28 789
Marlys Hammond United States 15 384 1.5× 426 2.0× 36 0.5× 54 0.7× 25 0.4× 24 778

Countries citing papers authored by Roberta Tesch

Since Specialization
Citations

This map shows the geographic impact of Roberta Tesch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberta Tesch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberta Tesch more than expected).

Fields of papers citing papers by Roberta Tesch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberta Tesch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberta Tesch. The network helps show where Roberta Tesch may publish in the future.

Co-authorship network of co-authors of Roberta Tesch

This figure shows the co-authorship network connecting the top 25 collaborators of Roberta Tesch. A scholar is included among the top collaborators of Roberta Tesch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberta Tesch. Roberta Tesch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tesch, Roberta, Lena M. Berger, Andreas Krämer, et al.. (2024). Development of Selective Pyrido[2,3- d ]pyrimidin-7(8 H )-one-Based Mammalian STE20-Like (MST3/4) Kinase Inhibitors. Journal of Medicinal Chemistry. 67(5). 3813–3842. 3 indexed citations
2.
Tesch, Roberta, Lena M. Berger, Monika Raab, et al.. (2023). Shifting the selectivity of pyrido[2,3-d]pyrimidin-7(8H)-one inhibitors towards the salt-inducible kinase (SIK) subfamily. European Journal of Medicinal Chemistry. 254. 115347–115347. 6 indexed citations
3.
Raab, Monika, Roberta Tesch, Sven Becker, et al.. (2021). The Small-Molecule Inhibitor MRIA9 Reveals Novel Insights into the Cell Cycle Roles of SIK2 in Ovarian Cancer Cells. Cancers. 13(15). 3658–3658. 13 indexed citations
4.
Tesch, Roberta, Monika Raab, Lena M. Berger, et al.. (2021). Structure-Based Design of Selective Salt-Inducible Kinase Inhibitors. Journal of Medicinal Chemistry. 64(12). 8142–8160. 26 indexed citations
5.
Pantsar, Tatu, Roberta Tesch, Lukas Grätz, et al.. (2021). Addressing a Trapped High-Energy Water: Design and Synthesis of Highly Potent Pyrimidoindole-Based Glycogen Synthase Kinase-3β Inhibitors. Journal of Medicinal Chemistry. 65(2). 1283–1301. 9 indexed citations
6.
Hanke, Thomas, Jong Fu Wong, Benedict‐Tilman Berger, et al.. (2020). A Highly Selective Chemical Probe for Activin Receptor-like Kinases ALK4 and ALK5. ACS Chemical Biology. 15(4). 862–870. 16 indexed citations
7.
Montenegro, Raquel Carvalho, Alison Howarth, Alessandro Ceroni, et al.. (2020). Identification of molecular targets for the targeted treatment of gastric cancer using dasatinib. Oncotarget. 11(5). 535–549. 32 indexed citations
8.
Berger, Benedict‐Tilman, Martin Schröder, A. Chaikuad, et al.. (2019). Fast Iterative Synthetic Approach toward Identification of Novel Highly Selective p38 MAP Kinase Inhibitors. Journal of Medicinal Chemistry. 62(23). 10757–10782. 19 indexed citations
9.
Tesch, Roberta, Tatu Pantsar, Eva Döring, et al.. (2019). Pyridinylimidazoles as dual glycogen synthase kinase 3β/p38α mitogen-activated protein kinase inhibitors. European Journal of Medicinal Chemistry. 175. 309–329. 26 indexed citations
10.
Tesch, Roberta, Christian F. W. Becker, Matthias Müller, et al.. (2018). An Unusual Intramolecular Halogen Bond Guides Conformational Selection. Angewandte Chemie International Edition. 57(31). 9970–9975. 14 indexed citations
11.
Silva, Rodrigo César da, Fabiana C. Vilela, Roberta Tesch, et al.. (2018). Design, Synthesis and Pharmacological Evaluation of Novel Antiinflammatory and Analgesic O-Benzyloxime Compounds Derived From Natural Eugenol. Letters in Drug Design & Discovery. 16(10). 1157–1166.
12.
Carvalho, Vinícius F., Tatiana Paula Teixeira Ferreira, François Noël, et al.. (2017). LASSBio-897 Reduces Lung Injury Induced by Silica Particles in Mice: Potential Interaction with the A2A Receptor. Frontiers in Pharmacology. 8. 778–778. 5 indexed citations
13.
Tesch, Roberta, et al.. (2014). Novel Potent Imidazo[1,2-a]pyridine-N-Glycinyl-Hydrazone Inhibitors of TNF-α Production: In Vitro and In Vivo Studies. PLoS ONE. 9(3). e91660–e91660. 17 indexed citations
14.
Tesch, Roberta, et al.. (2014). Acylhydrazone derivatives: a patent review. Expert Opinion on Therapeutic Patents. 24(11). 1161–1170. 55 indexed citations
15.
Alencar, A, Sharlene Lopes Pereira, Lı́dia Moreira Lima, et al.. (2014). N-acylhydrazone derivative ameliorates monocrotaline-induced pulmonary hypertension through the modulation of adenosine AA2R activity. International Journal of Cardiology. 173(2). 154–162. 32 indexed citations
16.
Richters, André, Debjit Basu, Julian Engel, et al.. (2014). Identification and Further Development of Potent TBK1 Inhibitors. ACS Chemical Biology. 10(1). 289–298. 23 indexed citations
17.
Barbosa, Maria Letícia de Castro, Lı́dia Moreira Lima, Roberta Tesch, et al.. (2013). Novel 2-chloro-4-anilino-quinazoline derivatives as EGFR and VEGFR-2 dual inhibitors. European Journal of Medicinal Chemistry. 71. 1–14. 126 indexed citations
18.
Alencar, A, Sharlene Lopes Pereira, Tadeu L. Montagnoli, et al.. (2013). Beneficial effects of a novel agonist of the adenosine A2A receptor on monocrotaline‐induced pulmonary hypertension in rats. British Journal of Pharmacology. 169(5). 953–962. 38 indexed citations
19.
Pereira, Sharlene Lopes, Arthur Eugen Kümmerle, Roberta Tesch, et al.. (2012). Antihypertensive profile of 2-thienyl-3,4-methylenedioxybenzoylhydrazone is mediated by activation of the A2A adenosine receptor. European Journal of Medicinal Chemistry. 55. 49–57. 36 indexed citations
20.
Tesch, Roberta, et al.. (2012). Phenylpiperazine derivatives: a patent review (2006 – present). Expert Opinion on Therapeutic Patents. 22(10). 1169–1178. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clive McCarthy Breakdown of academic impact, for papers by Ingo V. Hartung Breakdown of academic impact, for papers by Robert T. Lum Breakdown of academic impact, for papers by Friederike Stoll Breakdown of academic impact, for papers by Paolo Di Fruscia Breakdown of academic impact, for papers by Michael Härter Breakdown of academic impact, for papers by Ian L. Dale Breakdown of academic impact, for papers by Robert H. Bradbury Breakdown of academic impact, for papers by Esther Marco Breakdown of academic impact, for papers by Marlys Hammond
Rankless by CCL
2026